Document Detail


The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer.
MedLine Citation:
PMID:  11536038     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Promotion of apoptosis may potentiate the sensitivity of tumor cells to chemotherapeutic agents, thus improving the efficacy of cancer treatment. The transfection of the proapoptotic bax gene, which results in the overexpression of bax protein, augments the growth inhibition of A253 cells by BNP1350. Increased drug response was associated with the induction of DNA fragmentation in the size of 30-200 Kb, generating a cleaved fragment of 18 kDa from full-length 21 kDa bax and the cleavage of PARP. A253/vec cells treated with 0.07 microM(IC50) of BNP1350 accumulated in G2 phase at 24 h after drug removal. In contrast, A253/Bax cells treated with an equimolar concentration of BNP1350 primarily displayed a G1 phase accumulation with a concurrent decrease in G2 phase. Certain cell cycle regulatory protein expression and activities were altered following drug exposure in both cell lines under similar conditions. Cdk2- and cdc2-associated H1 kinase activities were markedly increased in the A253/Bax cell line with marginal increased activity in the A253/vec cell line. A chk1 activity assay was performed with GST-cdc25C (200-256) or GST-cdc25C(S216A) (200-256) fusion proteins as the substrate. Increased chk1 activity was observed in the A253/vec cell line, with little change in the A253/Bax cell line, when exposed to equimolar concentrations of BNP1350 (0.07 microM). A Western blot of immunoprecipitated chk1 indicated that increased chk1 phosphorylation following DNA damage induced by BNP1350 was accompanied by the observed G2 accumulation in the A253/vec cell line, while only a slight increase in chk1 phosphorylation was seen in the A253/Bax cell line. A decreased expression of cdc25C was observed in the BNP1350-treated A253/Bax cells, but not in the A253/vec cell line. Following exposure to BNP1350, increased binding of 14-3-3 proteins to chk1 occurred in both cell lines, with more being observed in the A253/vec cell line. The data have shown that inhibition of the chk1 pathway accompanied by the abrogation of G2 arrest is involved in sensitizing A253 cells to BNP1350 by bax gene transfer. These findings suggest that bax gene transfer sensitizes A253 cells to BNP1350 through apoptosis promoting and G2/M DNA damage checkpoint regulatory pathways.
Authors:
M Yin; G Hapke; B Guo; R G Azrak; C Frank; Y M Rustum
Related Documents :
15664638 - The effect of triethylene glycol dimethacrylate on the cell cycle of mammalian cells.
8516308 - Lethality induced by a single site-specific double-strand break in a dispensable yeast ...
15004698 - Identification of a restriction point at the m/g1 transition in cho cells.
6304118 - Induction of reverse transformation and normal cell cycle regulation by dibutyryl camp ...
21556798 - Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated i...
24439918 - Upregulation of a potential prognostic biomarker, mir-155, enhances cell proliferation ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Oncogene     Volume:  20     ISSN:  0950-9232     ISO Abbreviation:  Oncogene     Publication Date:  2001 Aug 
Date Detail:
Created Date:  2001-09-05     Completed Date:  2001-09-27     Revised Date:  2011-11-02    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  England    
Other Details:
Languages:  eng     Pagination:  5249-57     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Therapeutics, Grace Cancer Drug Center, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, New York, NY 14263, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis
CDC2 Protein Kinase / metabolism
Cell Cycle Proteins / metabolism*
Cell Line
Cyclin B / metabolism
DNA Fragmentation
Dose-Response Relationship, Drug
G2 Phase
Gene Expression Regulation, Enzymologic*
Gene Transfer Techniques*
Humans
Inhibitory Concentration 50
Lung Neoplasms / enzymology*,  genetics
Phosphorylation
Protein Binding
Protein Kinases / metabolism*
Proto-Oncogene Proteins / genetics*
Proto-Oncogene Proteins c-bcl-2*
Topoisomerase I Inhibitors*
Transfection
Tumor Cells, Cultured
bcl-2-Associated X Protein
cdc25 Phosphatases / metabolism*
Grant Support
ID/Acronym/Agency:
CA 16056/CA/NCI NIH HHS; CA 65761/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/BAX protein, human; 0/Cell Cycle Proteins; 0/Cyclin B; 0/Proto-Oncogene Proteins; 0/Proto-Oncogene Proteins c-bcl-2; 0/Topoisomerase I Inhibitors; 0/bcl-2-Associated X Protein; EC 2.7.-/Protein Kinases; EC 2.7.11.1/Checkpoint kinase 1; EC 2.7.11.22/CDC2 Protein Kinase; EC 3.1.3.48/CDC25C protein, human; EC 3.1.3.48/cdc25 Phosphatases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Thrombolytic therapy for adhesion of percutaneous central venous catheters to vein intima associated...
Next Document:  Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in...